This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. In this comprehensive guide, we’ll explore the intricacies of identifying such drugs and leveraging them for successful in-licensing opportunities.
The startup, which aims to develop lower-cost alternatives to branded medicines, has licensed two drugs from CStone Pharmaceuticals in a deal that could signal a coming price war in cancer immunotherapy.
Pharmanovia and Aeterna Zentaris have entered an exclusive licensing agreement for the latter’s medicine Ghryvelin (macimorelin). Under the deal, Pharmanovia will acquire the exclusive rights and license to commercialise Ghryvelin in the EEA and the UK from Consilient Health.
Women’s healthcare company TherapeuticsMD has sign ed agreements for licensing its products to the Mayne Pharma affiliate in the US. Additionally, TherapeuticsMD will grant Mayne the exclusive license to market Annovera in the US. Additionally, TherapeuticsMD will grant Mayne the exclusive license to market Annovera in the US.
It was commercially launched in the country in the same year under ELUNATE brand name. The post Takeda signs licensing agreement with HUTCHMED for fruquintinib appeared first on Pharmaceutical Technology. The China National Medical Products Administration (NMPA) approved fruquintinib for marketing in September 2018.
The NDA is supported by the data package licensed to Ocumension by Nicox as well as the Phase III clinical trial in China. Zerviate, 0.24% was compared to emedastine difumarate ophthalmic solution, 0.05%, an antihistamine, which is marketed under undeb Emadine brand name.
Plant Veda Receives License from CFIA to Produce Branded Products at New Facility Plant Veda Receives License from CFIA to Produce Branded Products at New Facility VANCOUVER, British Columbia–(BUSINESS WIRE)–Plant Veda Foods Ltd. CSE:MILK) (the “Company” or “Plant Veda”), an … Continue reading →
Sosei Heptares , a corporate brand of Sosei Group Corporation, has signed a new drug discovery partnership and option-to-license agreement with AbbVie for discovering, developing and marketing new therapies for neurological ailments. On signing of the deal, AbbVie will make an upfront payment of $40m to Sosei Heptares.
The gambit largely involves the use of compulsory licenses, which lets a country grant a license to a public agency or a generic drugmaker to copy a patented medicine without the consent of the brand-name company that owns the patent.
As per the terms of the license and distribution deal, Endo holds the exclusive right, which was also sublicensed to the affiliate of the company, Paladin Labs, to market the product in Canada on receiving regulatory approvals. A lead product of Quoin, QRX003 is a topical lotion intended to treat Netherton Syndrome.
The company expects its Covid-19 antiviral pill to be launched in the Chinese market on Friday, but noted that Sinopharm is the only legally authorized distributor there of molnupiravir, which is sold under the brand name Lagevrio and was developed by Merck and Ridgeback Biotherapeutics.
Additionally, Roche also markets MMF (under the brand name CellCept), an off-label immunosuppressive agent that is commonly prescribed to SLE and LN patients, although generic versions of MMF are also available throughout the 7MM.
Meanwhile, The Paleo Diet is seeking partners for a new licensing program, which will see it lend its trademark through full-branded and co-branded agreements. Available licensing categories include raw ingredients, prepared foods, meal delivery, software, services, personalized health care and consumer packaged goods (CPGs).
You can thank us for that 5 minute rabbit hole later), the social media giant has implemented yet another policy change affecting branded content for prescription drugs. A celebrity or influencer sponsored post on Instagram, which is owned by Facebook, endorsing a product is a common example of branded content.
Enters into License and Development Agreement with Amzell B.V. Enters into License and Development Agreement with Amzell B.V. Amring), a niche brand and generic pharmaceutical company, announced today an … Continue reading → Amring Pharmaceuticals Inc. Amring Pharmaceuticals Inc. BERWYN, Pa.–(BUSINESS
Heinz and Kraft Foods in 2015, costs were cut by $2 billion, but the combined company fought to grow sales of its long-running food brands in an era of changing tastes. The sales downturn led the company to report billions of dollars in write-downs on some of its brands, including Cool Whip, Oscar Mayer, Kraft and Maxwell House.
Calpol is probably the most well-known brand of paracetamol in liquid form for infants, toddlers and children. Today I will list Calpol alternative products, including other brands and forms of liquid paracetamol and alternative drugs. Boot’s brand of children’s paracetamol is another Calpol alternative. Sugar-free.
But the ways that brand companies license their patented drugs grant them market monopoly, preventing other entities from making generics so they can exclusively profit. Biomedical innovation reached a new era during the COVID-19 pandemic as drug development went into overdrive.
. “The International Delight team did a great job of capturing the craveable flavors of Fruity and Cocoa PEBBLES cereals in these new coffee creamers,” said Leah Broeders, head of licensing at Post Consumer Brands, in the same statement. ” Going Back in Time.
The Government recently announced the reclassification of fexofenadine 120mg, which will be available as General sale Medication (GSL), sold as branded products – Allevia 120mg tablets. Fexofenadine is known as generic product ‘fexofenadine’ and branded as Telfast. Summary of the post: What is fexofenadine?
The company’s last deal included an exclusive license agreement with the Cardiff, UK-headquartered specialty pharmaceuticals company Diurnal group for the commercialisation of Efmody (hydrocortisone) in Switzerland. The biotech transferred the rights for alendronate to Merck which marketed the drug under the brand name Vancapsi.
Known by the brand name Roctavian, BioMarin’s haemophilia A therapy valoctocogene roxaparvovec could be fairly priced in the range of $1.95–1.96 CSL Behring has a commercialisation and license agreement to develop EtranaDez. million, the think tank concluded in its updated evaluation.
Nytol Original and Nytol One a Night Nytol is probably the most known brand of over the counter sleeping aids. It is a pharmacy only medication licensed for ‘short-term’ treatment of pain experienced at the bedtime. Who should not have over the counter sleeping tablets? Nytol Original and One a Night is available only from pharmacies.
It has a history of buying up mature brands from other pharma companies, for example paying $300 million for rights to AstraZeneca’s migraine therapy Zomig (zolmitriptan) in a similar deal five years ago. Grünenthal will make the purchase in cash upfront, with the final figure dependent on any closing adjustments.
Licensed use. Popular brands of modified-release metformin: Sukkarto SR. There are other Sulfonylureas licensed in the UK to treat type-2 diabetes, but less commonly prescribed. Three most commonly used gliptins in the UK* (OpenPrescribing.net), in order, are: Sitagliptin (brand name: Januvia). Drug classification.
Ipsen’s consumer health range includes brands like diarrhoea remedy Smecta, Forlax for constipation and Ginkgo biloba supplement Tanakan, which recorded revenues of €226 million in 2021, up 8%. billion takeover of Clementia Pharma in 2019.
Novartis has added to its pipeline of radiopharmaceuticals pipeline once again, licensing a series of agents from iTheranostics that can be used to show where tumours are located in the body. . Novartis licenses the drug from Genmab and reformulated into its Sensoready autoinjector pen.
Many branded products are sold, which are equivalent to co-codamol. Some branded products contain more than 8mg of codeine phosphate per tablet. Codeine linctus is licensed for adults 18 years of age and over. . Codeine lintus is a pharmacy-only medicine licensed for the management of dry coughs. Co-codamol.
Conscious Greens is the first offering from Pairwise’s new brand, Conscious Foods. Pairwise teamed up with Performance Food Group (PFG) to co-brand its Purple Power Baby Greens Blend under PFG’s Peak Fresh Produce premium brand. Paul region, St. Louis and Springfield, Massachusetts.
Brand new UK startup RQ Biotechnology has been thrust into the spotlight after signing a $157 million licensing deal with AstraZeneca for monoclonal antibodies intended to protect vulnerable and immunosuppressed people from COVID-19.
The FDA also recommended that Gamida Cell generate additional manufacturing-related data prior to requesting a pre-Biologics License Application (BLA) meeting. During the meeting, the FDA provided encouraging feedback regarding the Phase 3 study of omidubicel pertaining to the pre-specified primary and secondary endpoints.
Ltd (“Juyou”), a biotechnology company that develops and sells medical and cosmetic skincare products, for the commercialization and development of Pliaglis ® in mainland China (the “License Agreement”).
million and US$1.8
Its pipeline product also comprises Xepol XP-28 which is used for the treatment of post-polio syndrome and is under pre-license sales among others. It markets products under the brand TARPEYO. Calliditas Therapeutics also partners with medical research institutions such as the Karolinska Institute and Uppsala University.
This transaction is pending approval from the bankruptcy court and the Federal Trade Commission (FTC), which is currently reviewing the potential sale; however, if given the green light, this deal could potentially be beneficial for both brands.
Biosimilars are increasingly becoming the standard of care and both have several licensed biosimilar drugs (e.g. As more trials show equivalency in outcomes between the branded and biosimilar product, more purchasers will choose the cheaper option. However, the financial success of these products is under threat.
The Bayer brand stands for trust, reliability and quality throughout the world. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. billion euros. billion euros.
The provision of these records must be readily available for auditing, and failing such regulatory audits can ultimately result in a license withdrawal. Both of these can ultimately deteriorate brand reputation. On top of this, if cyber-attacks are frequent, partners and consumers can become mistrusting. About the author.
Modafinil (brand name Provigil) is one of the primary drugs used in the management of narcolepsy in the UK. In the UK, modafinil has narrow licensed use. Well defined licensed use for modafinil means that an NHS doctor would only prescribe it to treat narcolepsy after an appropriate referral is made to a specialist. Atomoxetine.
Kesimpta (ofatumumab) started life as an oncology drug and was first developed by Genmab and licensed to GlaxoSmithKline who marketed under the brand name Arzerra to treat chronic lymphocytic leukaemia.
A friend of mine, who has very difficult to control cholesterol, was prescribed Livalo, an FDA-approved brand of the drug pitavastatin. He went to our site to discover that brand-name Livalo ( pitavastatin ). He went to our site to discover that brand-name Livalo ( pitavastatin ). Let’s call him John. Is the drug safe?
dacadoo licenses its technology, including its Health Score, to life and health insurance operators, supplying insurtech and health-tech solutions to over 35 of the top 100 life and health insurance operators globally. The app was released this month.
The deal covers global rights to three brands – Zinnat (cefuroxime axetil), Zinacef (cefuroxime) and Fortum (ceftazidime) – which are sold in more than 100 markets around the world and had sales of around $140 million last year.
In the UK, licensed forms of melatonin are prescribed either for the management of insomnia in adults over 55 years of age or to help with jet lag. The licensed use of Circadin is as follows: the short-term treatment of insomnia characterised by the poor quality of sleep in patients aged 55 or over. How to get melatonin in the UK?
Kesimpta started life as an oncology drug and was first developed by Genmab and licensed to GlaxoSmithKline who marketed under the brand name Arzerra to treat chronic lymphocytic leukaemia. GlobalData thinks Ocrevus will remain the most widely-used option, hitting $7.6 billion in sales in 2028.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content